# A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

> clinical trial · VERIFIED · 2025-05-01

Status: COMPLETED · Sponsor: Neurotech Pharmaceuticals · Condition: Retinitis Pigmentosa

- Company: Neurotech Pharmaceuticals
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT00447980

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.